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Acute oncogenic stress can activate autophagy and
facilitate permanent arrest of the cell cycle through
a failsafe mechanism known as oncogene-induced
senescence (OIS). Kaposi’s sarcoma-associated
herpesvirus (KSHV) proteins are known to subvert
autophagic pathways, but the link to Kaposi’s
sarcoma pathogenesis is unclear. We find that onco-
genic assault caused by latent KSHV infection elicits
DNA damage responses (DDRs) characteristic of
OIS, yet infected cells display only modest levels of
autophagy and fail to senesce. These aberrant
responses result from the combined activities of
tandemly expressed KSHV v-cyclin and v-FLIP
proteins. v-Cyclin deregulates the cell cycle, triggers
DDRs, and if left unchecked can promote autophagy
and senescence. However, during latency v-FLIP
blocks v-cyclin-induced autophagy and senescence
in a manner that requires intact v-FLIP ATG3-binding
domains. Together, these data reveal a coordinated
viral gene expression program that usurps auto-
phagy, blocks senescence, and facilitates the prolif-
eration of KSHV-infected cells.
INTRODUCTION
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the infec-
tious cause of Kaposi’s sarcoma (KS) (Chang et al., 1994). The
primary proliferative components in KS lesions are latently in-
fected ‘‘spindle cells’’ of presumed endothelial origin. Conse-
quently, gene products expressed within the KSHV latency
program are believed to be integral to KS pathogenesis (Ganem,
2010); however, it is not yet known precisely how these viral gene
products collaborate to drive spindle cell proliferation.
The KSHV latency program encodes a homolog of cellular
D-type cyclins, v-cyclin, that deregulates cellular proliferation.
v-Cyclin forms an active holoenzyme with cyclin-dependent
kinase 6 (CDK6), but also associates with CDK2, CDK4, and
CDK9. v-Cyclin-CDK6 heterodimers have a broader substrateCell Host &range than cellular D-type cyclin-CDK4/6 complexes and phos-
phorylate proteins involved in numerous phases of the cell cycle,
including the Retinoblastoma (Rb) protein and Cdc6 (Verschuren
et al., 2004b). Furthermore, v-cyclin-CDK6 complexes are
refractory to the action of Cip/Kip and INK4 families of cyclin-
dependent kinase inhibitors (CKIs) (Swanton et al., 1997; Ellis
et al., 1999; Mann et al., 1999). These properties enable v-cyclin
to potently drive DNA synthesis in a variety of cancer cell lines.
By contrast, v-cyclin expression in primary cells triggers robust
DNA damage checkpoint activation. These cells ultimately
undergo apoptosis or succumb to an irreversible form of cell-
cycle arrest known as oncogene-induced senescence (OIS)
(Koopal et al., 2007).
Chronic oncogene expression or inactivation of tumor sup-
pressor genes in primary cells can trigger OIS, a specialized
gene expression program that stably arrests cells in a metaboli-
cally active state (Adams, 2009). Increasingly, OIS is being
acknowledged as an important tumor suppressor mechanism
in vivo (Michaloglou et al., 2005). OIS triggered by the mutant
Ras oncogene serves as a paradigm for the senescence
response. In primary cells, Ras expression initially promotes
hyperproliferation and accrual of DNA damage, which triggers
activation of canonical DNA damage responses (DDRs) and
activation of the p53-p21 and INK4-Rb tumor suppressor path-
ways (Adams, 2009). Extensive characterization of Ras-induced
senescence has revealed that both pathways are necessary for
efficient acquisition of the senescent phenotype. The mecha-
nism of v-cyclin OIS is less well characterized, but there is
evidence that it is dependent on DDRs and an intact p53 check-
point (Verschuren et al., 2002; Koopal et al., 2007).
Autophagy, an important homeostatic mechanism for degrad-
ing long-lived or damaged macromolecules, was recently
demonstrated to promote Ras-induced senescence (Young
et al., 2009). Increased autophagic activity precedes Ras-
induced senescence and correlates with negative feedback on
the PI3K-mammalian target of rapamycin (mTOR) pathway.
Furthermore, silencing of key autophagy genes impairs Ras-
induced senescence. These findings suggest that autophagy
may be required to promote rapid protein turnover and facilitate
the induction of senescence in response to potent oncogenic
stress.
Autophagy also has important functions in aiding the clear-
ance of invading intracellular pathogens. The orchestratedMicrobe 11, 167–180, February 16, 2012 ª2012 Elsevier Inc. 167
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KSHV Controls Autophagy to Block Senescencecatabolism of foreign invaders by the autophagic machinery is
called ‘‘xenophagy’’ (Orvedahl and Levine, 2008). In xenophagy,
intracellular pathogens are encapsulated and degraded via
autophagic vesicles. Viral antigens processed by acidic prote-
ases in autolysosomes are loaded onto MHC-II in specialized
compartments and presented to CD4+ T cells (Paludan et al.,
2005). Many pathogens encode gene products that subvert
the cellular autophagic machinery. KSHV encodes two proteins,
viral Bcl-2 (v-Bcl-2) and viral FLICE inhibitory protein (v-FLIP),
which subvert the autophagic machinery. The v-Bcl-2 protein,
expressed during KSHV lytic replication, binds Beclin 1 to
interfere with activation of autophagy (Pattingre et al., 2005;
Wei et al., 2008; Liang et al., 2008). The v-FLIP protein, ex-
pressed within the KSHV latency program, binds Atg3 and
suppresses LC3 conjugation during autophagosome biogenesis
(Lee et al., 2009). Despite several reports identifying KSHV
proteins that can subvert autophagic pathways, no clear
evidence has emerged to link viral subversion of autophagy to
KS pathogenesis.
Here, we show that latent KSHV infection potently activates
DDRs but fails to trigger either autophagy or senescence,
indicating active viral evasion of the senescence program.
KSHV encodes v-cyclin and v-FLIP on the same multicistonic
latent transcript, suggesting that their functions during latency
may be interdependent. We demonstrate that v-cyclin and
v-FLIP coordinate an attack on the host senescence response.
Like oncogenic Ras, v-cyclin deregulates the cell cycle and
causes aberrant host DNA replication, resulting in damage that
triggers DDRs that lead to autophagy and cellular senescence.
However, we clearly demonstrate that v-FLIP suppresses
v-cyclin-inducedautophagic responsesandblocksOIS in latently
infectedcells. Taken together, thesefindings reveal acoordinated
viral gene expression program that has evolved to block senes-
cence to facilitate thegrowthanddivisionof latently infectedcells.
RESULTS
KSHV v-FLIP Suppresses Oncogene-Induced
Senescence
Latent KSHV infection triggers cellular DDRs and antiproliferative
checkpoints in host cells. Studies have linked these responses
to the latent v-cyclin protein, and have established that this
viral oncoprotein is capable of triggering senescence (Verschu-
ren et al., 2004a; Koopal et al., 2007). Indeed, we have observed
that among KSHV latent gene products only v-cyclin is capable
of inducing OIS (Figure S1A available online). However, it is
not yet known whether latent KSHV infection triggers senes-
cence. To address this directly, primary human foreskin fibro-
blasts (HFFs) were latently infected with KSHV and stained for
markers of DNA damage and senescence. Similar to v-cyclin-
expressing cells, fibroblasts latently infected with KSHV also
exhibited strong nuclear gH2AX foci, indicating extensive DNA
damage (Figures 1A and 1B and Figure S1B). Most v-cyclin-ex-
pressing cells stained positive for senescence-associated
b-galactosidase (SA b-gal) activity. By contrast, only 17% of
cells in the KSHV infected monolayer were SA b-gal positive.
Together, these results show that latent KHSV infection, despite
potently activating DDRs, fails to effectively trigger the senes-
cence of host cells.168 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 ElseThe failure of latently infected cells to senesce led us to
hypothesize that certain KSHV latent gene products may inter-
fere with the host senescence program. v-Cyclin is expressed
as part of a common transcription unit with LANA and v-FLIP
during latency (Figure 1C). To gauge the effects of LANA and
v-FLIP on v-cyclin OIS, we coexpressed these latent gene
products with v-cyclin in HFFs and assayed for DNA replica-
tion, DNA damage foci and senescence. We observed no
significant impact of LANA on v-cyclin OIS, but v-FLIP strongly
attenuated v-cyclin OIS, reducing the fraction of SA b-gal posi-
tive cells and the appearance of senescence-associated
heterochromatin foci (SAHF), a measure of the chromatin
condensation that defines senescence (Narita et al., 2003)
(Figures 1D–1F). v-FLIP also reversed the senescence-medi-
ated inhibition of DNA replication as measured by bromo-
deoxyuridine (BrdU) incorporation. Importantly, despite attenu-
ating v-cyclin OIS, v-FLIP had no impact on v-cyclin induced
DNA damage foci, suggesting that v-FLIP acts downstream
of the DDRs that drive OIS. Together, these findings suggest
that v-FLIP limits the antiproliferative effects of host DNA
damage responses triggered by v-cyclin, thereby allowing
the proliferation of latently infected cells. Intriguingly, v-FLIP
also suppressed expression of several markers of senescence
in Ras-expressing HFFs, suggesting a potential common
mechanism of v-FLIP-mediated senescence bypass (Figures
S1C and S1D).
Autophagic Activity Increases during v-Cyclin OIS
Autophagy is necessary for the efficient execution of senes-
cence in response to expression of the activated Ras oncogene
(Young et al., 2009), and the multifunctional v-FLIP protein has
recently been identified as a potent inhibitor of autophagy in
KSHV-infected lymphocytes and epithelial cells (Lee et al.,
2009). Thus, we hypothesized that (1), autophagy is required
for v-cyclin OIS; and (2), subversion of autophagy by v-FLIP
limits OIS. To determine whether autophagy is involved in
v-cyclin OIS, telomerase-immortalized primary microvascular
endothelial (TIME) cells were transduced with vectors encoding
v-cyclin or oncogenic HRasV12, and lysates were collected and
immunoblotted for markers of autophagy and senescence.
After 5 days, cell lysates expressing v-cyclin or HRasV12 dis-
played sharp increases in the autophagy marker LC3-II and the
senescence-associated high mobility group AT-hook protein-2
(HMGA2) compared to controls (Figure 2A and Figures S2A–
S2C). Because LC3-II is localized to autophagosomes it is
subject to autophagic degradation and recycling. Thus, the
observed increases in LC3-II levels during v-cyclin-induced
senescence could either reflect an increase in autophagic flux
or a blockade in the late stages of autophagy, thereby preventing
the genesis or function of autolysosomes and, in turn, preventing
LC3-II degradation. To distinguish between activation or
blockade in autophagy, cells undergoing v-cyclin-induced
senescence were treated with bafilomycin, a specific inhibitor
of lysosomal acidification that impairs autophagic degradation.
Similar to observations from Ras senescent cells, bafilomycin
treatment of v-cyclin senescent cells results in accumulation of
LC3-II relative to v-cyclin senescent cells treated with vehicle
control (Figures 2B and 2C), thereby confirming that v-cyclin
activates autophagy.vier Inc.
Figure 1. KSHV v-Cyclin OIS Is Suppressed by v-FLIP
(A) HFFs infected with KSHV, retrovirus encoding HA-v-cyclin, or controls at 7 days postinfection were assayed for SA b-gal activity (top row), gH2AX foci (red),
and LANA (green). DNA was counterstained with TO-PRO (blue). SA b-gal activity was assessed separately due to reagent autofluorescence.
(B) Quantification of SA b-gal activity and gH2AX foci from (A).
(C) Diagram of the latent transcription unit that encodes LANA, v-cyclin, and v-FLIP. v-FLIP translation initiates from an internal ribosomal entry site (IRES).
(D) HFFs simultaneously transduced with the appropriate combinations of empty retroviral vectors and vectors encoding HA-v-cyclin-IRES-blast (vcyc), v-FLIP-
myc-IRES-neo (v-FLIP), and/or LANA-IRES-puro (LANA), and after 5 days of selection were stained for SA b-gal activity (top row), SAHF (blue), and 53BP1
foci (red).
(E) Quantification of SA b-gal activity, SAHF, BrdU incorporation, and 53BP1 foci from (D).
(F) Immunoblots for LANA, HA-v-cyclin, and v-FLIP-myc (indicated by an *) in expression matrix employed in (D) and (E). Values are ± SEM of three independent
experiments. Not significant (ns), *p < 0.05, **p < 0.01, and ***p < 0.005 for the indicated parameters analyzed. See also Figure S1.
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Figure 2. Autophagy Is Upregulated during v-Cyclin OIS
(A) Immunoblot analysis of LC3 from TIME cells expressing HA-v-cyclin, HA-HRasV12, or vector at various days postselection (PS); accumulation of HMGA2 was
used asmarker of senescence and Lamin A/C served as a loading control. To quantify relative levels of LC3-II, band intensities were normalized to levels of Lamin
A/C in each lane and then expressed relative to vector control LC3-II levels.
(B and C) Immunoblot analysis of LC3 derived from vector control (Vec) cells or senescent HA-v-cyclin (vcyc) and HA-HRasV12 (HRas) TIME cells and HFFs,
respectively, 5 days PS in the absence or presence of 100 nM Bafilomycin A1 (Baf) for 3 hr prior to lysis. LC3-II levels were quantified as above.
(D) Electron microscopy (EM) of senescent HA-v-cyclin and HA-HRasV12 TIME cells or proliferating controls 7 days PS.
(E) Quantification of autophagic structures per cell section in (D).
(F) SA b-gal activity within the populations used for EM analysis. Values are ± SEM of two independent experiments. *p < 0.05 and ***p < 0.005 for the indicated
parameters analyzed.
(G) Confocal images of senescent HA-v-cyclin and HA-HRasV12 TIME cells or controls transfected with mCherry-EGFP-LC3 for the visualization of autopha-
gosomes (yellow puncta) and autolysosomes (red puncta). See also Figure S2.
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senescent cells were replete with autophagosomes and autoly-
sosomes, whereas proliferating empty vector cells had compar-170 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 Elseatively few autophagosomes (Figures 2D–2F). v-Cyclin expres-
sion also promoted relocalization of diffuse cytoplasmic
mCherry-EGFP-LC3 reporter proteins into discrete cytoplasmicvier Inc.
Figure 3. v-Cyclin Senescence Involves Negative Feedback on mTOR Signaling
(A) Clonal Tet-off HA-v-cyclin inducible TIME cells were assayed for BrdU incorporation, SA b-gal activity, and protein expression at various days after removal of
doxycycline.
(B) HFFs transduced with the indicated retroviral vectors 7 days PS or starved in EBSS for 4 hr were assessed for changes in mRNA levels via Q-RT-PCR. Data
was normalized to actin and analyzed using the 2^(-DDCT) method. Values are ± SEM of three separate experiments.
(C) Immunoblotting for mTOR pathway proteins and downstream effectors in lysates derived from v-cyclin inducible TIME cells at various days after removal of
doxycycline. See also Figure S3.
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KSHV Controls Autophagy to Block Senescencepuncta that marked the location of autophagosomes (Fig-
ure 2G). This fusion protein also allowed discrimination of auto-
phagosomes (yellow) from mature autolysosomes (red) in which
EGFP fluorescence had been quenched in the acidic microenvi-
ronment (Pankiv et al., 2007). Similar to Ras senescent cells, we
observed a significant proportion of mature autolysosomes in
v-cyclin expressing cells, and further accumulation of autolyso-
somes in bafilomycin-treated cells, indicating an increased auto-
phagic flux (Figure 2G and Figures S2D and S2E). By contrast,
the mCherry-EGFP-LC3 reporter exhibited diffuse cytoplasmic
staining in proliferating control cells. Taken together, these find-
ings confirm that autophagy is activated during v-cyclin-induced
senescence.
Activation of DRAM and Sestrin1 Correlates with
Negative Feedback on mTOR Signaling and Activation
of Autophagy during v-Cyclin OIS
To determine the status of signaling pathways that may
contribute to autophagy activation in v-cyclin-expressing cells,Cell Host &we developed a tetracycline-responsive expression system in
TIME cells. Following induction of v-cyclin expression, the
percent of proliferating and senescent cells over an 8 day period
was assessed via BrdU-incorporation and SA b-gal staining,
respectively. In this system, v-cyclin induced a modest increase
in the percent of cells that incorporated BrdU after 1 day of
expression, followed by a sharp decrease that coincided with
induction of senescence as measured by SA b-gal activity
(Figure 3A). These results indicated that v-cyclin, like other
senescence-inducing oncogenes, initially promoted a period
of hyperproliferation followed by transition into senescence.
Immunoblots from this time course show that v-cyclin rapidly
promoted accumulation of gH2AX, followed by LC3-II and
HMGA2, which synchronously increased3 days after induction
and persisted throughout the remainder of the experiment
(Figure 3A). The levels of cyclin A, a marker of cell proliferation,
decreased dramatically after induction of v-cyclin and were
undetectable by day 3. Surprisingly, we found a negligible
increase in the levels of INK4a during v-cyclin-inducedMicrobe 11, 167–180, February 16, 2012 ª2012 Elsevier Inc. 171
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ing experiments employing a retroviral ectopic expression
system (Figure S2B). Together, these results suggest that our
inducible v-cyclin expression system faithfully recapitulates
features of v-cyclin OIS, including triggering DNA damage and
autophagy prior to the full onset of senescence.
Activation of autophagy during Ras-induced senescence
correlates with negative feedback on mTOR, the well-described
master regulator of cell growth and autophagy (Young et al.,
2009). Although little is known about cellular genes that function
in v-cyclin-induced senescence, p53 is strongly activated in cells
expressing v-cyclin and is necessary for proliferation arrest
(Figure S2B and Verschuren et al., 2004a). p53 is known to regu-
late the expression of several genes that have been linked
to autophagy and OIS, including damage-regulated autophagy
modulator (DRAM), Sestrin1, and Sestrin2 (Crighton et al.,
2006; Budanov and Karin, 2008). We observed that v-cyclin sen-
escent cells strongly upregulate DRAM and Sestrin1 expression,
whereas Ras senescent cells display increases in both Sestrin1
and Sestrin2 (Figure 3B). Cells subjected to serum and amino
acid starvation activated autophagy (Figures S3A and S3B) but
failed to upregulate DRAM, Sestrin1, or Sestrin2, indicating
that upregulation of these genes is not a universal feature of
autophagy, but instead may be limited to OIS. The potent upre-
gulation of p21 and HMGA2 and concomitant downregulation
of cyclin A in v-cyclin-expressing and Ras-expressing cells
confirmed that these cells were undergoing OIS and that p53
was activated in this process. In agreement with previous exper-
iments we found that INK4a was exclusively upregulated in Ras
senescent and not v-cyclin senescent TIME cells (Figure 3B).
Furthermore, this experiment confirmed that autophagy is
a general feature of OIS; both v-cyclin and Ras upregulated
the autophagy genes ULK1, ULK3, ATG7, LC3A, and LC3B (Fig-
ure 3B). Collectively, these findings indicate that v-cyclin triggers
the induction of a discrete set of autophagy regulating genes that
set the stage for OIS.
The upregulation of DRAM and Sestrin1 during v-cyclin OIS
suggests these proteins may contribute to the activation of auto-
phagy. Although DNA damage can trigger autophagy via p53-
dependent expression of DRAM, the precise function of this
lysosomal protein remains to be elucidated. By contrast, Ses-
trins activate autophagy via AMP-responsive protein kinase
(AMPK), which phosphorylates the TSC2 subunit of TSC1:TSC2
complexes (Budanov and Karin, 2008). TSC2 functions as
a GTPase-activating protein (GAP) for the small GTPase Rheb,
a direct activator of mTOR. Thus, Sestrin-directed AMPK phos-
phorylation of TSC2 stimulates its GAP activity, decreasing
Rheb-GTP levels and inhibiting mTOR signaling. To determine
the involvement of this signaling axis in v-cyclin triggered
autophagy and OIS, we immunoblotted protein lysates from a
5 day expression time course. We observed early activation
of p53, upregulation of DRAM and Sestrin1, and AMPK Thr172
phosphorylation (Figure 3C). By day 3, mTOR was inactivated,
as measured by loss of Ser2448 phosphorylation and simulta-
neous loss of phosphorylation of mTOR target proteins S6K
and 4EBP1. Although these events suggest a role for Sestrin1
in inhibiting mTOR via AMPK, we also observed a loss in
Akt Thr308 and Ser473 phosphorylation, suggesting that redun-
dant mechanisms may facilitate mTOR inhibition. Furthermore,172 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 Elsethe apparent loss of mTOR activity correlated with strong accu-
mulation of LC3-II and HMGA2. Experiments performed on an
additional clonal isolate of inducible TIME-v-cyclin cells confirm
these findings (Figure S3C). By contrast, Ras-inducible cells
upregulated Sestrin 1 and Sestrin 2 protein expression during
senescence, but failed to upregulate DRAM, suggesting that
these oncogenes may inactivate mTOR via similar but distinct
mechanisms (Figure S3D). Together, these data strongly sug-
gest that v-cyclin triggers autophagy by activating a DNA
damage-sensing pathway that results in mTOR inhibition.
v-cyclin-CDK6 complexes phosphorylate a broad range of
host proteins, including Bcl2 (Ojala et al., 2000), a well-described
anti-apoptotic protein that has also been implicated in repres-
sion of autophagy (Pattingre et al., 2005). Phosphorylation
of Bcl2 relieves its repressive effect on Beclin-1, allowing the
formation of a class III PI-3-kinase complex that is necessary
to initiate autophagosome formation (Wei et al., 2008). Surpris-
ingly, we were unable to detect p-Ser70 Bcl-2 in our v-cyclin
expressing cells. By contrast, control docetaxel-treated cells
displayed a marked increase in p-Ser70 Bcl-2 levels (Figure 3C).
The absence of detectable Bcl-2 phosphorylation, coupled
with pronounced loss of mTOR activity during the period of
autophagy activation, suggest that autophagy is triggered in
v-cyclin-senescing TIME cells via negative feedback on mTOR
signaling and not due to derepression of Beclin 1.
Deficiencies in p53 and Autophagy Signaling Impair
v-Cyclin-Induced Senescence
To determine whether autophagy is required for efficient execu-
tion of v-cyclin-induced senescence, we transduced HFFs with
shRNAs targeting the essential autophagy genes ATG5 and
ATG7, as well as the senescence-regulating checkpoint genes
p53 and Rb1. In accord with previous reports, we observed
v-cyclin-induced senescence to be p53-dependent (Koopal
et al., 2007) (Figures 4A, 4B, and 4D); p53-deficient HFF-v-cyclin
cells showed dramatically reduced SA b-gal activity and
increased BrdU incorporation. By contrast, Rb1 deficiency had
only a modest impact on SA b-gal activity and BrdU incorpora-
tion. Furthermore, by employing shRNAs targeting ATG5
or ATG7 we demonstrated that autophagy is necessary for
the efficient execution of v-cyclin OIS. These findings were
confirmed in a clonogenic assay: we observed striking increases
in colony formation (indicative of senescence bypass) in cells
transduced with shRNAs targeting p53 and ATG7, with compar-
atively modest effects in cells deficient for Rb1 and ATG5 (Fig-
ure 4C). Taken together, our results indicate that the functions
of p53 and autophagy are necessary for the establishment of
v-cyclin OIS.
Dysregulated Cytokine Production Is a Feature
of v-Cyclin OIS
Previous work has shown that the dramatic phenotypic changes
in OIS are accompanied by increased secretion of several key
cytokines including IL-1a, IL6, and IL8 (Coppe´ et al., 2008; Orjalo
et al., 2009). It is thought that this senescence-associated secre-
tory phenotype (SASP) may be the result of the reprogramming
of translation that accompanies OIS, and there is evidence that
certain cytokine signaling networks are important for enforcing
senescence (Acosta et al., 2008; Kuilman et al., 2008). Here wevier Inc.
Figure 4. p53 and Autophagy Signaling Are Necessary for Efficient v-Cyclin OIS
(A and B) Tert-immortalized HFFs were transduced with retroviral vectors and selected in neomycin for 7 days. Subsequently, knockdown cells and scrambled
controls (Scr.) were transduced with HA-v-cyclin or vector (Vec) and selected in puromycin. At 4 days PS transduced cells were either (A) assayed for SA b-gal
activity or (B) BrdU incorporation. Values are ± SEM of three independent experiments. *p < 0.05, **p < 0.01 for the indicated parameters analyzed.
(C) HFF knockdown cells transducedwith HA-v-cyclin were analyzed for colony formation. At 8 days PS cells were seeded at the indicated densities and after two
weeks stained with crystal violet to visualize clonal outgrowth.
(D) Immunoblots demonstrating silencing of targets from (A) and (B). Relative LC3 II levels were quantified as in Figure 2.
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SASP cytokines, IL-1a, IL-1b, IL6, and IL8, during the period of
transition to senescence in HFFs and TIME cells (Figures 5A
and 5B). This response is autophagy-dependent; disruption of
autophagy with shRNAs targetingATG5 or ATG7 effectively sup-
pressed IL6 and IL8 release (Figures 5C and 5D). This cytokine
response provides further support for the idea that v-cyclin trig-
gers autophagy-dependent OIS in a manner reminiscent of
oncogenic ras. KS tumors harbor elevated levels of proinflam-
matory cytokines and growth factors that are thought to
contribute to tumorigenesis, including the SASP-associated
cytokines investigated in our study. Our data suggests thatCell Host &v-cyclin may significantly contribute to cytokine dysregulation
in KS tumors.
KSHV v-FLIP Suppresses v-Cyclin-Induced Autophagy
To determine whether v-FLIP blocks v-cyclin OIS via suppres-
sion of autophagy, HFF cells were simultaneously transduced
with v-cyclin and v-FLIP or mutant v-FLIP expression vectors,
and then transiently transfected with a GFP-LC3 reporter.
v-FLIP mutants with either reduced capacity to activate NF-kB
(v-FLIP 58AAA) or compound defects in both NF-kB activation
and ATG3 binding (v-FLIP Da2a4), were employed to specifically
dissect v-FLIP functions that may impinge upon v-cyclin OISMicrobe 11, 167–180, February 16, 2012 ª2012 Elsevier Inc. 173
Figure 5. Autophagy Contributes to a v-Cyclin SASP
(A) TIME cells or HFFs transduced with HA-v-cyclin retroviral vector or controls at 8 days PS were assessed for changes in mRNA levels for IL1a, ILb, IL6, and IL8
via Q-RT-PCR. Data was normalized to b-actin and analyzed using the 2^(-DDCT) method. Values are ± SEM of two separate experiments.
(B–D) Conditioned media from the populations in (A) were analyzed for the levels of IL6 and IL8 at 8 days PS via ELISA. Cytokine levels were normalized to cell
number. Values are ± SEM of two separate experiments. To examine the impact of autophagy on chemokine secretion HFF knockdown cells transduced with
HA-v-cyclin or control vector were analyzed for IL6 (C) or IL8 (D) via ELISA at various days PS. Values were normalized as in (B) and are ±SEM of two independent
experiments. ns > 0.05 and *p < 0.01 the indicated parameters analyzed.
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KSHV Controls Autophagy to Block Senescence(Lee et al., 2009). As expected, v-cyclin-expressing cells ex-
hibited strong 53BP1 puncta, GFP-LC3 puncta, and SA b-gal
activity (Figures 6A–6C). Specifically, we found that for cells ex-
pressing v-cyclin and the GFP-LC3 reporter, 75% contained
>30 autophagic puncta per cell, and 76% displayed SA b-gal
activity. Cotransduction of v-FLIP with v-cyclin had no appre-
ciable effect on DDRs, but markedly reduced the number of cells
with >30 cytoplasmic GFP-LC3 puncta (53%) and SA b-gal
activity (31%). Similar to cells coexpressing wild-type v-FLIP,
NF-kB signaling-defective v-FLIP 58AAA and v-cyclin cotrans-
ductants exhibited, on average, relatively few GFP-LC3 puncta
per cell (41%) and demonstrated a small but significant increase
in the proportion of cells with SA b-gal activity (56%). Impor-
tantly, cells cotransduced with v-cyclin and v-FLIP Da2a4
rendered high proportions of cells with >30 autophagic puncta
per cell (79%) and SA b-gal staining (85%) (Figures 6A–6C).
These results demonstrate that v-FLIP-mediated suppression
of autophagy is sufficient to suppress v-cyclin OIS, and suggest
an intriguing auxiliary role for NF-kB signaling.174 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 ElseRescue of Autophagic Function in KSHV-Infected Cells
Promotes Senescence
Despite several reports identifying KSHV proteins that can
subvert autophagic pathways, the status of autophagy in
KSHV infected cells and its impact on viral pathogenesis has
yet to be thoroughly examined. Our preliminary investigations
revealed that a recombinant GFP-expressing KSHV (Zhou
et al., 2002) displayed more efficient infection of HFFs when
autophagy was impaired via shRNA-mediated inhibition of
ATG7 (Figure S4A), suggesting that autophagy may normally
restrict KSHV infection. Furthermore, latently KSHV infected
HFFs displayed modest levels of GFP-LC3 puncta and SA
b-gal staining, suggesting that autophagy may be actively sup-
pressed during latency (Figure S4B). Thus, we surmised that
inhibition of v-FLIPs autophagy suppressing activity would
expose KSHV to the anti-proliferative effects of OIS. To this
end, we constructed retroviral vectors encoding red fluorescent
protein (RFP) fused to ATG3-binding peptides derived from
v-FLIP (RFP-a2; RFP-a4), which have been shown to stronglyvier Inc.
Figure 6. KSHV v-FLIP Suppresses Autophagy to Impair v-Cyclin OIS
(A) HFFs transduced with the appropriate combinations of empty retroviral vectors (Vec), and/or vectors encoding HA-v-cyclin-IRES-blast (vcyc) and v-FLIP-
myc-IRES-neo (v-FLIP) or v-FLIP mutant constructs were assayed for SA b-gal activity at 7 days postinfection (top row), GFP-LC3 autophagic puncta (green),
53BP1 DNA damage foci (red), and LANA (blue).
(B) Quantification of cells that stain positive for SA b-gal and have >30 autophagosomes from (A). Values are ± SEM of three independent experiments.
(C) Immunoblots for HA-v-cyclin, v-FLIP-myc (indicated by arrows), and actin from lysates in (A).
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KSHV Controls Autophagy to Block Senescenceinteract with and ablate the anti-autophagic functions of wild-
type v-FLIP (Lee et al., 2009), and tested their ability to restore
autophagy in KSHV-infected cells. In control cells, we again
observed that latent KSHV infection confers modest levels of
autophagy, as measured by GFP-LC3 puncta, and low levels
of senescence (Figures 7A and 7B). By contrast, latently infected
cells expressing RFP-a2 or RFP-a4 v-FLIP inhibitory peptides
display elevated levels of autophagy and senescence. TheseCell Host &peptides specifically target v-FLIP function in KSHV infected
cells; we observed no measurable impact on autophagy or
senescence in uninfected controls (Figure S4C). Rapamycin,
like the v-FLIP inhibitory peptides, has been demonstrated to
induce autophagy, and may have therapeutic applications for
KS (Campistol et al., 2004; Izzedine et al., 2005). For this reason,
we tested the ability of rapamycin to induce autophagy and
senescence in KSHV infected cells; exposure of latently infectedMicrobe 11, 167–180, February 16, 2012 ª2012 Elsevier Inc. 175
Figure 7. Rescue of Autophagic Function in KSHV-Infected Cells Promotes Senescence
(A) HFFs were transduced with RFP-a2 or RFP-a4 v-FLIP inhibitory peptides or an RFP control vector and subsequently infected with KSHV. We observed
that >95% of cells were latently infected. One day prior to analysis, these cells were transfected with a GFP-LC3 reporter construct to visualize auto-
phagosomes.
(B) Quantification of cells that stain positive for SA b-gal and have >30 autophagosomes from (A) and uninfected controls (representative images displayed in
Figure S4).
(C) HFFswere infectedwith KSHV for 3 days to establish latency, and treatedwith 10 nM rapamycin for 5 days. One day prior to SA b-gal staining, a parallel culture
of cells was transfected with a GFP-LC3 reporter construct to visualize autophagosomes.
(D) Quantitation of cells that stain positive for SA b-gal from (C). Values are ±SEM of three independent experiments. *p < 0.05 and **p < 0.01 for the indicated
parameters analyzed.
(E) Proposed model for the coordinate regulation of DNA damage, autophagy and senescence in KSHV latently infected cells. See also Figure S4.
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KSHV Controls Autophagy to Block Senescencecells to rapamycin results in increased autophagy and senes-
cence, consistent with the notion that suppression of autophagic
flux by the virus is necessary to evade OIS (Figures 7C and 7D
and Figure S4D). Furthermore, these findings suggest that
therapeutic targeting of autophagy may be efficacious in the
treatment of KS, targeting the latently infected spindle cells
that are the hallmark of KS tumors.176 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 ElseDISCUSSION
Like all herpesviruses, KSHV is able to establish persistent latent
infection in host cells. KSHV latency depends on the coordinated
expression of a handful of viral gene products that together serve
to maintain the viral episome, evade recognition of viral products
by the immune system, and promote the long-term survival ofvier Inc.
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KSHV Controls Autophagy to Block Senescenceinfected host cells. Here, we describe how KSHV latent gene
products control cellular senescence. In our working model,
v-cyclin activity in latently infected cells, if left unchecked,
causes aberrant host DNA replication resulting in double-strand
breaks that trigger DDRs, autophagy, and ultimately cellular
senescence (Figure 7E). Accumulating evidence suggests that
senescence is an important host defense mechanism in limiting
the effects of oncogenic viruses (Nikitin et al., 2010). In the case
of KSHV infection, we demonstrate that the virus expresses
a countermeasure, the v-FLIP protein, which inhibits autophagy
and blocks the host senescence response. Our study describes
an autophagy-dependent senescence response to an oncovirus,
and the viral countermeasure to this response that allows latently
infected cells to proliferate despite the accrual of DNA damage.
Our understanding of the control of host responses in latently
infected cells remains incomplete. We clearly demonstrate
that p53 is activated in v-cyclin OIS, and is essential for the
efficient execution of downstream autophagy and senescence
responses. For these reasons, we were surprised to find that
KSHV LANA, a p53-binding protein that has been shown to block
transactivation of p53-responsive genes in ectopic overexpres-
sion studies (Friborg et al., 1999), had no impact on v-cyclin
OIS. KS and PEL tumors typically possess wild-type p53 and
respond clinically to treatment with the DNA-damaging agent
doxorubicin, indicating intact p53 activity in tumor cells (Katano
et al., 2001; Nador et al., 1996; Petre et al., 2007; Dittmer and
Krown, 2007). More recent studies have demonstrated that
LANA only binds a minor fraction of total p53 in KSHV-positive
primary effusion lymphoma tumor cells, and that this interaction
is sensitive to p53 Ser15 phosphorylation (Chen et al., 2010). For
these reasons, it seems likely that LANA fails to block v-cyclin
OIS because v-cyclin-induced DDRs cause rapid disassembly
of p53:LANA complexes.
KSHV v-cyclin promotes OIS by deregulating host DNA repli-
cation and eliciting DDRs that trigger autophagy and cellular
senescence. We performed a thorough characterization of the
molecular mechanism of v-cyclin OIS, and observed a striking
upregulation of p53 target genes DRAM and Sestrin1, and acti-
vation of the Sestrin target protein AMPK. AMPK activity has
previously been implicated in OIS (Moiseeva et al., 2009), but
the effects of AMPK on autophagy in OIS remain unexplored to
date. We demonstrate that like oncogenic Ras, v-cyclin-induced
AMPK activation coincided with suppression of mTOR, strongly
correlating with the induction of autophagy. RNA silencing of
p53, or the essential autophagy genes ATG5 and ATG7, sup-
pressed v-cyclin-induced autophagy and delayed the acquisi-
tion of the senescent phenotype. These findings highlight
the importance of these key p53 target genes in mediating
the suppression of mTOR, a central node in the control of
autophagy. However, our understanding of these pathways
remains incomplete. Recent work has revealed an mTOR-inde-
pendent mechanism for the initiation of autophagy via direct
phosphorylation of the autophagy-initiating kinase ULK1 by
AMPK on multiple serine residues (Kim et al., 2011). Thus, by
potently activating AMPK v-cyclin may trigger both mTOR-
dependent and mTOR-independent pathways leading to activa-
tion of autophagy.
Herpesviruses are subject to regulation by autophagy and,
in turn, encode countermeasures to subvert autophagic pro-Cell Host &cesses. Several herpesviruses, including KSHV, encode Bcl2-
like proteins that inhibit autophagy by direct interaction with
the Beclin1 autophagy protein (Pattingre et al., 2005; Liang
et al., 2006; Ku et al., 2008). These proteins are expressed during
the lytic cycle, concurrent with viral assembly, and are thought to
limit the ability of the autophagic machinery to target newly
assembled virions for degradation (xenophagy) or inhibit the
autophagy-facilitated presentation of viral antigens to the
immune system. By contrast, it has not been clear why a latent
KSHV gene product, v-FLIP, evolved to inhibit autophagy. Here,
we provide compelling evidence for v-FLIP-mediated control of
the host OIS program, but could there be other functions driving
the evolution of this latent inhibitor of autophagy? Clearly, it
would not be to block xenophagy, because no new viral particles
are made during latency. Autophagy has been suggested as the
main degradation pathway for long-lived proteins, and has been
shown to be required for the efficient presentation of EBV EBNA1
latent antigen to CD4 T cells (Paludan et al., 2005). Thus, in addi-
tion to blocking host antiproliferative responses to v-cyclin
expression, v-FLIP could also promote evasion of autophagy-
mediated presentation of latent viral antigens. Inspection of
the latent gene expression programs of related gammaherpesvi-
ruses reveals the presence of a LANA/v-cyclin/v-FLIP transcrip-
tional unit in rhesus rhadinoviruses and herpesvirus saimiri but,
intriguingly, the extensively studied murine gammaherpesvirus-
68 (MHV-68), encodes LANA and v-cyclin homologs, but no
homolog of v-FLIP. Instead, MHV-68 encodes M11, a latently
expressed v-Bcl2 homolog in the same genomic location that
v-FLIP would be expected to occupy (Barton et al., 2011). It
will be interesting to test whetherMHV-68 has acquired a distinct
negative regulator of autophagy during its evolution that serves
the same role as KSHV v-FLIP, blocking antiproliferative host
responses, or perhaps even disrupting autophagy-mediated
presentation of latent viral antigens.
In addition to suppressing autophagy, v-FLIP has a well-
described role in stimulating the NF-kB pathway; it binds and
activates the multiprotein IKK complex and promotes transcrip-
tion of an array of NF-kB-responsive genes (Chaudhary et al.,
1999; Liu et al., 2002). Recent work has demonstrated that NF-
kB signal transduction impacts autophagy and senescence.
Activation of the NF-kB signal transduction pathway has been
shown to potently stimulate autophagy (Criollo et al., 2009) and
promote OIS (Rovillain et al., 2011; Chien et al., 2011), but
there have also been conflicting reports that implicate elevated
NF-kB activity and/or secretion of inflammatory mediators in
senescence bypass (Coppe´ et al., 2008; Batsi et al., 2009;
Groppo and Richter, 2011; Guerra et al., 2011). Furthermore,
many studies have shown that tumor cells that bypass senes-
cence have elevated NF-kB activity and/or aberrant cytokine
secretion profiles (Grivennikov et al., 2010). Our findings indicate
that v-FLIP suppression of autophagy is sufficient to suppress
v-cyclin OIS, but also suggest an intriguing auxiliary role for
v-FLIP-mediated dysregulation of the IKK/NF-kB signaling axis
in suppressing OIS.
In summary, our work illuminates an important host mecha-
nism that serves to limit the effects of oncogenic viruses by
triggering cellular senescence, and identifies a viral strategy
to undermine these defenses. The co-evolution of this latent
transcriptional unit highlights the importance of autophagyMicrobe 11, 167–180, February 16, 2012 ª2012 Elsevier Inc. 177
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KSHV Controls Autophagy to Block Senescenceregulation in KSHV infection, and suggests that autophagy may
represent an ‘‘Achilles heel’’ in the cellular senescence response,
easily thwarted by viral oncoproteins that have evolved to specif-
ically block its effects.EXPERIMENTAL PROCEDURES
Vectors and Cell Culture
Vectors, cloning, cell culture, and infections are detailed in the Supplemental
Experimental Procedures. Target sequences for shRNAs are in Table S1.Cell Proliferation, Colony Formation, SA-b-Gal Assays, and SAHF
BrdU incorporation and immunolabeling were performed according to
manufacturer’s instructions (BD). Briefly, cells were pulsed with 100 mM
BrdU for 4 hr or 8 hr (for BJ and TIME cells, respectively) prior to processing.
Ten fields of 25–50 cells/field were enumerated for each of three indepen-
dent experiments.
To carry out colony formation assays, transduced BJ-tert cells, 8 days post-
selection (PS), were seeded in duplicate at 2,500 or 5,000 cells/35 mm well.
Two weeks later, cells were fixed and stained with 0.5% crystal violet (Sigma).
Washed and dried plates from two independent experiments were scanned for
visualization.
Senescent cells were detected using an SA b-gal kit according to manufac-
turers instructions (NEB). SA b-gal activity was assayed separately using cells
derived from a single population due to reagent autofluorescence. Ten fields of
50 cells were enumerated in three separate experiments. For detection of
SAHF, cells were fixed and permeabilized in 90% methanol and stained with
0.13 mg/ml DAPI for 2 min. Ten fields of 25 cells/field were enumerated in three
independent experiments.Immunofluorescence and Electron Microscopy
Immunofluorescence
Cells were seeded on gelatin-coated coverslips were fixed in 4% paraformal-
dehyde, permeabilized in 90% methanol, and blocked in 3% FBS. Primary
antibodies were incubated with samples overnight at 4C followed by incuba-
tion with fluorescent secondary antibodies (Molecular Probes) for 1 hr. All fluo-
rescent samples were visualized with either a Zeiss Axiovert 200 microscope
with a Hamamatsu Orca camera or a Zeiss LSM 510 META Laser Scanning
Confocal Microscope as indicated.
Electron Microscopy
Transduced cells at 7 days PS were trypsinized, resuspended in ice-cold full
media, and pelleted. Subsequently, cells were fixed at room temperature for
1 hr in 0.1 M Sorensen’s phosphate buffer containing 3.5% glutaraldehyde.
Samples were postfixed in phosphate buffered 1% osmium tetroxide, dehy-
drated in ethanol, and embedded in epoxy resin for thin sectioning followed
by standard staining in uranium and lead salts. Thin sections were observed
in a JEOL JEM-1230 transmission electron microscope equipped with a
Hamamatsu ORCA-HR. The criteria outlined in (Yla¨-Anttila et al., 2009) were
employed to enumerate the number of autophagic structures per cell section,
in 30 cells in two independent experiments.Fluorescence Microscopy of Autophagic Structures
To visualize autophagic structures for fluorescent microscopy experiments we
transfected senescing cells or proliferating controls 5 days after addition of
selection with either pDEST-mCherry-EGFP-LC3 or pDEST-EGFP-LC3 (Terje
Johansen, Tromsø). Cells were transfected with PEI and Lipofectamine LTX,
respectively. Media was refreshed 24 hr posttransfection and 4 hr later cells
were fixed in 4% paraformaldehyde for 15 min. Cells were either visualized
directly for autophagic structures or then permeabilized in ice-cold 90%meth-
anol for costained fluorescencemicroscopy. At least 30 cells were evaluated in
three separate experiments.Gene Expression
Sample preparation and analysis of gene expression are detailed in Supple-
mental Experimental Procedures.178 Cell Host & Microbe 11, 167–180, February 16, 2012 ª2012 ElseIL6 and IL8 ELISAs
The concentration of chemokines released into the supernatant wasmeasured
via specific IL-6 or IL-8 ELISA (BD OptEIA). The data were normalized to cell
number and reported as ng per 1 3 106 cells/day.
Statistics
Data was analyzed using an unpaired, two-tailed, Student’s t test, with 95%
confidence on Prism GraphPad.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.chom.2012.01.005.
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